Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04645173 · ClinicalTrials.gov registry record
Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation
A clinical trial, sponsored by Elutia.
- Completed
- Registry status
- 46
- Enrollment target
NCT04645173 is a clinical trial that has completed, run by Elutia. The registered enrollment target is 46 participants.
The verdict
NCT04645173 has completed, sponsored by Elutia.
- COMPLETED
- Registry status
- 46 participants
- Enrollment target
Study Summary
The objective of this study is to gather information on participants returning at time of CIED change-out or revision who underwent a device implantation with either a CanGaroo® envelope, TYRX™ envelope, or no envelope.
Interventions
- DEVICE CIED envelope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2021-02-02 |
| Est. Completion | 2023-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04645173
The ClinicalTrials.gov registry entry for NCT04645173 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Elutia, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CIED envelope is the first listed.
NCT04645173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04645173 about?
NCT04645173 is a clinical study titled "Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation". The objective of this study is to gather information on participants returning at time of CIED change-out or revision who underwent a device implantation with either a CanGaroo® envelope, TYRX™ envelope, or no envelope.
What is the current status of trial NCT04645173?
This trial is currently completed. The enrollment target is 46 participants. The study started on 2021-02-02. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04645173?
The interventions under investigation include: CIED envelope (DEVICE).
Who is sponsoring clinical trial NCT04645173?
This trial is sponsored by Elutia, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.